Sort
59,101 grants matching “hypertension”
Therapeutic Modulation of Atrial Remodeling
$695,882David S Park · New York University School Of Medicine · R01 · FY2024 · HL
Racial/Ethnic Influences on Early Vascular Aging and Cardiac Strain: Role of Cumulative Stress, Inflammatory and Metabolic Burden
$695,861Uma Rao · University Of California-Irvine · R01 · FY2023 · HL
Animal Models for Studying the Genetics of Hypertension
$695,845University Of North Carolina Chapel Hill · R01 · FY2004 · HL
Clinical and mechanistic role of HDGF in pulmonary hypertension
$695,821Allen D Everett · Johns Hopkins University · R01 · FY2017 · HL
Reaching Equity for Adults and CHildren in Transplant (REACH-TRANSPLANT)
$695,718Elaine Ku · University Of California, San Francisco · R01 · FY2022 · DK
An Experimental Investigation into the Impact of Socioeconomic Context on Biological Markers of Aging, Health and Mortality
$695,712Peter A Muennig · Columbia University Health Sciences · R01 · FY2019 · AG
PEGylated megahemoglobin for use as a red blood cell substitute
$695,646Andre Francis Palmer · Ohio State University · R01 · FY2020 · HL
The impact of enculturation on the epigenetic relationship between chronic stress and hypertension in Yup'ik Alaska Native people
$695,639Bert Brandon Boyer · Oregon Health & Science University · R01 · FY2022 · MD
Role of proteolytic suPAR fragment in insulin dependent diabetes and kidney disease
$695,626Sanja Sever · Massachusetts General Hospital · R01 · FY2023 · DK
IGF::OT::IGF Vascular Interventions/Innovations and Therapeutic Advances (VITA): IND Enabling Studies for a Novel Inhaled PDGF Receptor Inhibitor to Treat PAH
$695,615Lawrence Zisman · Pulmokine, Inc. · N01 · FY2015 · HL
WNK-SPAK signaling in the Distal Nephron
$695,612Eric J Delpire · Vanderbilt University Medical Center · R01 · FY2024 · DK
Proteomic determinants of direct measures of insulin sensitivity
$695,603Themistocles Leonard Assimes · Stanford University · R01 · FY2020 · DK
Epidemiological and Genetic Studies of Body Mass Index
$695,588Boston University Medical Campus · R01 · FY2003 · HL
Characterization of Coagulation Factor-platelet Interactions: Role of FXI
$695,571Owen J McCarty · Oregon Health & Science University · R01 · FY2020 · HL
Mechanisms of VSM dysfunction in diabetes and HFpEF
$695,543Manuel F Navedo · University Of California At Davis · R01 · FY2025 · HL
Forebrain electroneutral transporters in salt-sensitive hypertension
$695,521Megan M Wenner · University Of Delaware · R01 · FY2024 · HL
Taxi Health Access Interventions for Linkages and Lifestyle (HAILL)
$695,504Francesca M Gany · Sloan-Kettering Inst Can Research · R01 · FY2019 · NR
SMI Dual Eligibles and Medicare Part D: Impact on Medications Continuity and Outc
$695,453Donald M Steinwachs · Johns Hopkins University · R01 · FY2010 · MH
Novel Regulators of Calcific Aortic Valve Disease
$695,452Mehran M Sadeghi · Yale University · R01 · FY2019 · HL
Counseling older Americans to control hypertension (COACH)
$695,437Gbenga Godwin Ogedegbe · Columbia University Health Sciences · P60 · FY2009 · MD
The Okla Achukma Project
$695,436Jennifer Lemacks · University Of Southern Mississippi · R56 · FY2022 · HL
Project 1: Endothelial cell programs for coronary artery disease
$695,419Rajat M Gupta · Stanford University · P01 · FY2025 · HL
Proposal for a Chicago-CRIC Clinical Center
$695,412James P Lash · University Of Illinois At Chicago · U01 · FY2007 · DK
Theraputic targeting of pulmonary endothelial cells to inhibit pathological lung remodeling
$695,403Tanya Kalin · University Of Arizona · R01 · FY2025 · HL
Activation of the Angiopoietin-Tie2 Pathway to Treat Ocular Hypertension and Glaucoma
$695,357Susan E Quaggin · Northwestern University At Chicago · R01 · FY2018 · EY